Cite

    Kwatra, S. et al. (n.d.). 343 Dupilumab efficacy on itch and skin lesions in adult patients with prurigo nodularis may be observed concurrently or independently over 24 weeks: results from two phase 3 trials. British journal of dermatology. p. . [Online].